MS and MND Flashcards

1
Q

Describe MS

A

Inflammatory plaques of demyelination in CNS which are disseminated in time and space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Subtypes of MS

A

Relapsing remitting
Primary progressive
Secondary progressive (secondary to relapsing remitting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Age of onset in MS and MND

A

MS: ~30 years
MND: >40 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Common presentation of MS

A

Unilateral optic neuritis (20%)
Corticospinal involvement
Urine retention or incontinence
Symptoms worsen with heat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical features of MS (11 points)

A
Sensory loss
Neuropathic pain
Spastic muscle weakness
Urine retention/incontinence
Constipation
Sexual dysfunction
Dysphagia
Optic neuritis
Internuclear ophthalmoplegia 
Cerebellar signs
Cognitive decline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Criteria for MS

A

McDonald:
At least 2 attacks lasting >1 hour and are >30 days apart
AND
Disseminated in time and space (clinical or MRI evidence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnosis of MS

A

T2 weighted MRI brain and spinal cord with contrast
LP for oligoclonal IgG bands on electrophoresis of CSF
Visual evoked response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effect of pregnancy on MS

A

During pregnancy relapses may reduce
After giving birth relapses may increase for 3-6 months
Frequency returns to previous rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of MS

A

Lifestyle: exercise, stop smoking, vitamin D supplements
Disease modifying drugs: dimethyl fumarate, monoclonal antibodies (alemtuzumab)
Relapse drugs: methylprednisolone for 3-5 days
Symptom control (bladder, bowel, pain, spasticity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment for spasticity

A

Baclofen

Gabapentin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment for tremor in MS

A

Botulinum toxin injections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management of urinary symptoms in MS

A

Self catheterisation if RV >100ml

Tolteridone if RV <100ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe MND

A
Loss of neurones in:
Motor cortex
Cranial nerve nuclei
Anterior horn of spinal cord 
(Mixed UMN and LMN signs)

No sensory loss
No sphincter disturbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 4 different clinical patterns of MND

A

ALS
Progressive bulbar palsy
Progressive muscular atrophy
Primary lateral sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does ALS stand for

A

Amyotrophic lateral sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe ALS

A

Loss of motor neurones in motor cortex and anterior horn of spinal cord leading to UMN and LMN signs

17
Q

Describe progressive bulbar palsy

A

LMN signs affecting cranial nerves 9-12

Results in difficulty talking and swallowing

18
Q

Describe progressive muscular atrophy

A

Anterior horn cell lesion so LMN signs

Distal muscles affected earlier than proximal

19
Q

Describe primary lateral sclerosis

A

Loss of neurones in motor cortex so UMN signs

Spastic leg weakness and pseudobulbar (damage to corticobulbar tracts)

20
Q

Contrast bulbar and pseudobulbar palsy

A

Bulbar is LMN lesion of muscles of talking and swallowing, pseudobulbar is UMN lesion of muscles of talking and swallowing
Pseudobulbar has increased jaw jerk, slow speech and mood incongruence

21
Q

What other progressive condition is associated with MND

A

Frontotemporal dementia in 25%

22
Q

Diagnosis of MND

A

No diagnostic test:
MRI excludes structural causes
LP excludes inflammatory causes
Myasthenia antibodies

23
Q

Disease modifying drugs for MND

A

Riluzole - NMDA antagonist

24
Q

Symptom management for MND

A
Salivation - antimuscurinics (glycopyrronium bromide)
Dysphagia - blend food, gastrostomy 
Spasticity - baclofen or gabapentin
Alternative communication equipment
Non invasive ventilation overnight
25
Q

Prognosis of MND

A

50% <3 years